“There’s been a lot of lip service to equity in New Zealand’s pandemic response but the fine words […]
The UCL study will evaluate the safety and effectiveness of MTL-CEBPA in combination with second line standard of […]
Novartis UK has announced that the MHRA has given a positive scientific opinion for the investigational treatment, asciminib
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use aliu Tue, 01/25/2022 […]
Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward completion fkansteiner Tue, 01/25/2022 – 10:56
Roche’s aim to widen Evrysdi’s label nabs speedy FDA review in young spinal muscular atrophy patients fkansteiner Tue, […]
Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform kdunleavy Tue, 01/25/2022 – […]
Argenx, already deep into its Vyvgart launch, charts course to become immunology ‘powerhouse’: CEO fkansteiner Mon, 01/24/2022 – […]
A BMA representative for armed forces doctors has secured a legal victory obliging the Ministry of Defence to […]
In their trial of a programme to prevent falls in older people, Logan and colleagues show that training […]